Sponsor 2022

Sponsor 2022

Miltenyi Biotec

www.miltenyibiotec.com


10 Rue Mercoeur
75011 PARIS


Solène SERGENT - Client Sales Manager
solene@miltenyi.com

01 56 98 16 16


Tél : 01 56 98 16 16

Miltenyi Biotec is a global provider of products and services that advance biomedical research and cellular therapy. Since 1989, we have developed innovative and reliable technologies for scientists and clinicians around the world. Our integrated portfolio of tools covers techniques of sample preparation, cell separation, flow cytometry, cell culture, molecular analysis, and preclinical imaging. The MACS® brand has set standards worldwide and is trusted across basic, translational, and clinical research settings. Our expertise covers research areas like immunology, stem cell biology, neuroscience, and cancer, and clinical research areas that include hematology, graft engineering, as well as apheresis.  We are committed to supporting scientists and the scientific community – from comprehensive technical support to training at our MACS Academy. Today, we are more than 2,000 employees in 22 countries – all dedicated to providing solutions that empower scientific discovery and advance cellular therapy.   

Actualités

Miltenyi : New modules to expand processing capabilities of the CliniMACS Prodigy® Platform: electroporation and final formulation

August 05, 2022

The CliniMACS Prodigy represents the next generation in automated cell processing. This device offers advanced integrated solutions to streamline cell processing workflows – from cell separation through cell culture to...

Learn more

New automated process to simplify the manufacturing of gene-engineered NK Cells and Treg cells isolation

July 28, 2022

To address the variety of Treg cell applications, Miltenyi Biotec provides a broad range of tools for clinical use.

Learn more

The MACSima™ Imaging Platform is the only complete solution for ultra high content imaging experiments.

September 13, 2021

Learn more

New automated process to simplify the manufacturing of gene-engineered hematopoietic stem cells with the CliniMACS Prodigy® HSC Engineering System

September 13, 2021

Learn more
Voir toutes les actualités

Retrouvez-aussi